Can't hide much longer

The July 4 recess in Washington brings a short respite from the tortured attempts to ram health care reform through Congress. As we Commented on June 27, even the Congressional Budget Office has concluded that price controls will stifle incentives to invest in drug R&D. But that hasn't stopped